-
Sector Analysis
United Kingdom Meat Substitutes Market Opportunities, Trends, Growth Analysis and Forecast to 2027
UK Meat Substitutes Market Overview The UK meat substitutes market was valued at GBP 623 million ($770.8 million) in 2022 and is expected to grow at a CAGR of more than 5% during the period 2022-2027. Single cell protein (Fungi/Algae) was the largest category in volume terms in 2022. The category is also forecast to register the fastest volume growth during 2022–2027, followed by soy based and vegetable/plant-based proteins. UK Meat Substitutes Market Outlook, (GBP Million, 2022) For more insights...
-
Product Insights
Vivera Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Vivera Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Vivera Pharmaceuticals Inc, is an innovative, science-driven pharmaceutical company that focuses on opioid cessation and deterrence and non-addictive solutions for pain management. The company is headquartered in United States. GlobalData's Medical Devices company profile report, “Vivera Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile...
-
Product Insights
COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 enzyme immuno assay/enzyme linked immunosorbent assay (EIA/ELISA) is the most widely used assays having high sensitivity and specificity. They are used to detect the recombinant protein and peptide antigens in the samples. The COVID-19 EIA/ELISA pipeline product report provides comprehensive information about the pipeline products with comparative analysis at various stages of development and information about the clinical trials which are in progress. The report also provides key information and clinical trial data regarding ongoing clinical trials such as...
-
Product Insights
COVID 19 point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 point of care (POC) tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. The COVID-19 POC tests pipeline products report provides comprehensive information about the COVID 19 point of care tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides information on the pipeline products...
-
Product Insights
COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) – Medical Devices Pipeline Assessment, 2020
COVID 19 EIA/ELISA are the most widely used assays having high sensitivity and specificity. They are used to detect the recombinant protein and peptide antigens in the samples. ELISA’s are specifically designed to screen large number of samples at a time. GlobalData's Medical Devices sector report, “COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) -Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) pipeline products with comparative analysis of...
-
Product Insights
COVID 19 Nucleic Acid Amplification Tests (NAATs) – Medical Devices Pipeline Assessment, 2020
COVID 19 NAAT tests are highly sensitive tests and can easily detect the low density infections. The types of NAAT tests are Polymerase chain reaction (PCR) – including nested (n), quantitative (q) or real-time reverse transcription (RT) PCR), quantitative nucleic acid sequence-based amplification (QT-NASBA) and loop mediated isothermal amplification (LAMP). GlobalData's Medical Devices sector report, “COVID 19 Nucleic Acid Amplification Tests (NAATs) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 Nucleic Acid Amplification Tests (NAATs)...
-
Product Insights
COVID 19 point of care (POC) Tests – Medical Devices Pipeline Assessment, 2020
COVID 19 Point of Care (POC) Tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. GlobalData's Medical Devices sector report, “COVID 19 point of care (POC) Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Analyst Opinions
Ingredient Insights: Opportunities in Meat Substitutes
"Ingredient Insights: Opportunities in Meat Substitutes" is part of GlobalData's research into how consumer attitudes towards alternative proteins are changing in the FMCG sector. The report analyses the evolution to date, drivers and inhibitors, and the future trends emerging from increased consumption of meat alternatives. This report covers the growing acceptance and embracement of meat alternatives as a viable part of diets globally. It explores how consumer attitudes have evolved and the drivers behind these changes. Demographic and regional nuances...